Drug Shortage Report for VAQTA
Report ID | 32720 |
Drug Identification Number | 02229702 |
Brand name | VAQTA |
Common or Proper name | hepatitis A vaccine, purified inactivated Suspension for injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | HEPATITIS A VACCINE, INACTIVATED |
Strength(s) | 50UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 50U/1ML 1DOSE VIAL (ADULT) |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-02-02 |
Actual start date | 2018-01-11 |
Estimated end date | 2018-03-26 |
Actual end date | 2018-03-26 |
Shortage status | Resolved |
Updated date | 2018-03-27 |
Company comments | Remaining doses are reserved for the public immunization program. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2018-03-27 | English | Compare |
v9 | 2018-03-26 | English | Compare |
v8 | 2018-03-16 | English | Compare |
v7 | 2018-01-24 | French | Compare |
v6 | 2018-01-24 | English | Compare |
v5 | 2018-01-12 | English | Compare |
v4 | 2018-01-11 | French | Compare |
v3 | 2018-01-11 | English | Compare |
v2 | 2017-12-13 | French | Compare |
v1 | 2017-12-13 | English | Compare |
Showing 1 to 10 of 10